Adaprolol beta blocker in a submicron emulsion formulation data

PARS (New York) presented early clinical data at the Fort Lauderdale meeting, showing that Adaprolol reduced intraocular pressure (p<0.01) in 63 patients as did the comparison beta blocker, timolol. In contrast to timolol, the company's product did not reduce systolic blood pressure. ...